Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · IEX Real-Time Price · USD

237.83

+1.13 (0.48%)

At close: Jul 19, 2024, 4:00 PM

237.85

+0.02 (0.01%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Alnylam Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2003
Revenue	2,003	1,828	1,037	844.29	492.85	219.75	Upgrade
Revenue Growth (YoY)	75.20%	76.23%	22.88%	71.31%	124.28%	193.36%	Upgrade
Cost of Revenue	321.51	310.41	168.82	140.14	78.05	25.06	Upgrade
Gross Profit	1,682	1,518	868.6	704.14	414.8	194.69	Upgrade
Selling, General & Admin	822.78	795.65	770.66	620.64	588.42	479.01	Upgrade
Research & Development	1,035	1,004	883.02	792.16	654.82	655.11	Upgrade
Operating Expenses	1,858	1,800	1,654	1,413	1,243	1,134	Upgrade
Operating Income	-175.8	-282.18	-785.07	-708.65	-828.44	-939.43	Upgrade
Interest Expense / Income	127.52	121.22	155.97	143.02	84.5	0	Upgrade
Other Expense / Income	21.42	30.12	185.95	0.47	-57.33	-54.18	Upgrade
Pretax Income	-324.74	-433.52	-1,126.99	-852.14	-855.6	-885.25	Upgrade
Income Tax	7.33	6.73	4.16	0.68	2.68	0.86	Upgrade
Net Income	-332.08	-440.24	-1,131.16	-852.82	-858.28	-886.12	Upgrade
Shares Outstanding (Basic)	126	125	122	118	115	109	Upgrade
Shares Outstanding (Diluted)	126	125	122	118	115	109	Upgrade
Shares Change	1.63%	2.64%	2.73%	3.01%	5.24%	8.62%	Upgrade
EPS (Basic)	-2.64	-3.52	-9.30	-7.20	-7.46	-8.11	Upgrade
EPS (Diluted)	-2.67	-3.52	-9.30	-7.20	-7.46	-8.11	Upgrade
Free Cash Flow	127.82	41.95	-613.33	-718.07	-685.32	-418.58	Upgrade
Free Cash Flow Per Share	1.01	0.34	-5.04	-6.06	-5.96	-3.83	Upgrade
Gross Margin	83.95%	83.02%	83.73%	83.40%	84.16%	88.60%	Upgrade
Operating Margin	-8.78%	-15.43%	-75.68%	-83.93%	-168.09%	-427.50%	Upgrade
Profit Margin	-16.58%	-24.08%	-109.04%	-101.01%	-174.15%	-403.24%	Upgrade
Free Cash Flow Margin	6.38%	2.29%	-59.12%	-85.05%	-139.05%	-190.48%	Upgrade
EBITDA	-100.79	-215.27	-885.48	-619.43	-696.67	-830.89	Upgrade
EBITDA Margin	-5.03%	-11.77%	-85.35%	-73.37%	-141.35%	-378.10%	Upgrade
Depreciation & Amortization	96.44	97.03	85.55	89.69	74.44	54.37	Upgrade
EBIT	-197.22	-312.3	-971.03	-709.12	-771.1	-885.25	Upgrade
EBIT Margin	-9.84%	-17.08%	-93.60%	-83.99%	-156.46%	-402.85%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).